Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000886744-17-000010
Filing Date
2017-02-10
Accepted
2017-02-10 20:00:01
Documents
1
Period of Report
2017-02-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3922
  Complete submission text file 0000886744-17-000010.txt   5378
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Issuer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 651 GATEWAY BLVD STE 950 SOUTH SAN FRANCISCO CA 94080
Business Address
GRETHLEIN ANDREW J (Reporting) CIK: 0001270921 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20859 | Film No.: 17595374